Your Location: Set Your Location HomeCOVID-19 (Coronavirus) UpdatesCOVID-19 Monoclonal Antibody Treatment COVID-19 (Coronavirus) Updates Patients Critical Patient Updates Visitors Hospital & Clinic Visitor Guidelines Community Members COVID-19 Testing COVID-19 Monoclonal Antibody Treatment Monoclonal Antibody Treatment Eligibility Do you have questions about eligibility for COVID-19 monoclonal antibody treatment? Call Toll Free Monday - Friday: 8 am - 4:30 pm 1-833-769-1524 Essentia Health offers a treatment for people at high risk for severe complications from COVID-19 who are either diagnosed with mild-to-moderate COVID-19 or as a preventive treatment following a close-contact COVID-19 exposure for people who are unvaccinated (or fully vaccinated and immunocompromised or immunosuppressed). Patients must meet certain criteria set by the FDA to qualify for the treatment. The drugs, Regeneron’s casirivimab and imdevimab and Lilly’s bamlanivimab and etesevimab, are monoclonal antibodies authorized for emergency use by the federal Food and Drug Administration (FDA). They must be given within 10 days of the start of symptoms and as soon as possible after a positive COVID-19 test or following a close-contact exposure. There is a limited supply of these drugs. They are being allocated by federal and state agencies. Due to the limited supply of the drugs, eligible patients are randomly chosen by a computer for treatment. Those patients are contacted by a registered nurse from Essentia Health and then scheduled for an intravenous infusion. Randomized selection is an ethical method for choosing who gets access to the treatment when supply is limited. People who have a positive COVID-19 test at any Essentia Health site are automatically screened for the FDA’s criteria and placed in the eligibility pool for randomization. Those who were tested at other sites can call a toll-free hotline at 1-833-769-1524 to be screened for the eligibility pool. Hotline hours are 8:30 a.m. to 5 p.m. Monday-Friday. Health care providers can refer a patient by calling Essentia Health’s STAT Doc line. Essentia Health offers the outpatient therapy at these locations: Duluth: Essentia Health-Miller Hill Health Plaza, 1600 Miller Trunk Hwy, Bldg. C Fargo: Essentia Health-32nd Avenue Clinic, 3000 32nd Ave. S. Fargo: Essentia Health-South University Clinic, 1702 University Dr S Brainerd: Essentia Health-St. Joseph’s Medical Center, 523 N 3rd St. Ada: Essentia Health-Ada, 201 Ninth St. W. Deer River: Essentia Health-Deer River, 115 10th Ave. N.E. Detroit Lakes: Essentia Health St. Mary's-Detroit Lakes Clinic, 1027 Washington Ave. Fosston: Essentia Health-Fosston, 900 Hilligoss Blvd. S.E. Graceville: Essentia Health-Holy Trinity Hospital, 115 W. Second St. FAQs What is a close-contact encounter? Who is eligible for treatment? What are the risk factors identified by the FDA? What are monoclonal antibodies? Where does Essentia Health offer this therapy? What is an investigational drug? What does this treatment require? How does a patient ask for this treatment? How does Essentia Health select patients for this treatment? What are the possible side effects of monoclonal antibodies? What does monoclonal antibody treatment cost? Is it covered by health insurance? FDA Information Regeneron Fact Sheet for Patients, Parents, and Caregivers Bamlanivimab and Etesevimab Fact Sheet for Patients, Parents, and Caregivers SCROLL TO TOP Essentia Health is an integrated health system serving patients in Minnesota, Wisconsin, and North Dakota. News For Vendors For Employees For Medical Professionals Contact Us Privacy Policy Language Services Copyright 2021 Essentia Health. All rights reserved. Like most websites, we use cookies and other technologies to keep our website reliable, secure, and to better understand how our site is used. By using our site, you agree to our use of these tools. Learn more.